CLINICAL_TRIALS
trial_result
· 2019-08-08
Clinical Trial Update: Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma [Phase 2]
Summary
Phase 2 clinical trial evaluating decitabine in combination with oxaliplatin for metastatic renal cell carcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zhejiang Cancer Hospital | Conditions: Metastatic Renal Cell Carcinoma | Phase 2 | Status: UNKNOWN